China Acute Myeloid Leukemia Therapeutics Market Report & Forecast 2021-2027

China Acute Myeloid Leukemia Therapeutics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Acute Myeloid Leukemia Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Acute Myeloid Leukemia Therapeutics Overall Market Size
2.1 China Acute Myeloid Leukemia Therapeutics Market Size: 2021 VS 2027
2.2 China Acute Myeloid Leukemia Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Myeloid Leukemia Therapeutics Players in China Market
3.2 Top China Acute Myeloid Leukemia Therapeutics Companies Ranked by Revenue
3.3 China Acute Myeloid Leukemia Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia Therapeutics Companies in China Market, by Revenue in 2020
3.5 Companies Acute Myeloid Leukemia Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia Therapeutics Players in China Market
3.6.1 List of Tier 1 Acute Myeloid Leukemia Therapeutics Companies in China
3.6.2 List of Tier 2 and Tier 3 Acute Myeloid Leukemia Therapeutics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Acute Myeloid Leukemia Therapeutics Market Size Markets, 2021 & 2027
4.1.2 Pipeline Drugs
4.1.3 Chemotherapy Drugs
4.1.4 Chemotherapy Regimens
4.2 By Type - China Acute Myeloid Leukemia Therapeutics Revenue & Forecasts
4.2.1 By Type - China Acute Myeloid Leukemia Therapeutics Revenue, 2016-2021
4.2.2 By Type - China Acute Myeloid Leukemia Therapeutics Revenue, 2022-2027
4.2.3 By Type - China Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Acute Myeloid Leukemia Therapeutics Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application - China Acute Myeloid Leukemia Therapeutics Revenue & Forecasts
5.2.1 By Application - China Acute Myeloid Leukemia Therapeutics Revenue, 2016-2021
5.2.2 By Application - China Acute Myeloid Leukemia Therapeutics Revenue, 2022-2027
5.2.3 By Application - China Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2016-2027
6 Acute Myeloid Leukemia Therapeutics Companies Profiles
6.1 Ambit Biosciences Corporation
6.1.1 Ambit Biosciences Corporation Company Details
6.1.2 Ambit Biosciences Corporation Business Overview
6.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction
6.1.4 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.1.5 Ambit Biosciences Corporation Recent Developments
6.2 Genzyme Corporation Celgene Corporation
6.2.1 Genzyme Corporation Celgene Corporation Company Details
6.2.2 Genzyme Corporation Celgene Corporation Business Overview
6.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction
6.2.4 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.2.5 Genzyme Corporation Celgene Corporation Recent Developments
6.3 Clavis Pharma ASA
6.3.1 Clavis Pharma ASA Company Details
6.3.2 Clavis Pharma ASA Business Overview
6.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction
6.3.4 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.3.5 Clavis Pharma ASA Recent Developments
6.4 Sunesis Pharmaceuticals
6.4.1 Sunesis Pharmaceuticals Company Details
6.4.2 Sunesis Pharmaceuticals Business Overview
6.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction
6.4.4 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.4.5 Sunesis Pharmaceuticals Recent Developments
6.5 Cephalon
6.5.1 Cephalon Company Details
6.5.2 Cephalon Business Overview
6.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction
6.5.4 Cephalon Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.5.5 Cephalon Recent Developments
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Details
6.6.2 Bristol-Myers Squibb Business Overview
6.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction
6.6.4 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.6.5 Bristol-Myers Squibb Recent Developments
6.7 Novartis International AG
6.7.1 Novartis International AG Company Details
6.7.2 Novartis International AG Business Overview
6.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction
6.7.4 Novartis International AG Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.7.5 Novartis International AG Recent Developments
6.8 GlaxoSmithKline
6.8.1 GlaxoSmithKline Company Details
6.8.2 GlaxoSmithKline Business Overview
6.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction
6.8.4 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021)
6.8.5 GlaxoSmithKline Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Acute Myeloid Leukemia Therapeutics Market Opportunities & Trends in China Market
Table 2. Acute Myeloid Leukemia Therapeutics Market Drivers in China Market
Table 3. Acute Myeloid Leukemia Therapeutics Market Restraints in China Market
Table 4. Key Players of Acute Myeloid Leukemia Therapeutics in China Market
Table 5. Top Acute Myeloid Leukemia Therapeutics Players in China Market, Ranking by Revenue (2019)
Table 6. China Acute Myeloid Leukemia Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Acute Myeloid Leukemia Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Companies Acute Myeloid Leukemia Therapeutics Product Type
Table 9. List of Tier 1 Acute Myeloid Leukemia Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Acute Myeloid Leukemia Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Acute Myeloid Leukemia Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Acute Myeloid Leukemia Therapeutics Revenue (US$, Mn), 2022-2027
Table 17. Ambit Biosciences Corporation Company Details
Table 18. Ambit Biosciences Corporation Business Overview
Table 19. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Product
Table 20. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Ambit Biosciences Corporation Recent Developments
Table 22. Genzyme Corporation Celgene Corporation Company Details
Table 23. Genzyme Corporation Celgene Corporation Business Overview
Table 24. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Product
Table 25. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Genzyme Corporation Celgene Corporation Recent Developments
Table 27. Clavis Pharma ASA Company Details
Table 28. Clavis Pharma ASA Business Overview
Table 29. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Product
Table 30. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Clavis Pharma ASA Recent Developments
Table 32. Sunesis Pharmaceuticals Company Details
Table 33. Sunesis Pharmaceuticals Business Overview
Table 34. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Product
Table 35. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Sunesis Pharmaceuticals Recent Developments
Table 37. Cephalon Company Details
Table 38. Cephalon Business Overview
Table 39. Cephalon Acute Myeloid Leukemia Therapeutics Product
Table 40. Cephalon Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Cephalon Recent Developments
Table 42. Bristol-Myers Squibb Company Details
Table 43. Bristol-Myers Squibb Business Overview
Table 44. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Product
Table 45. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Bristol-Myers Squibb Recent Developments
Table 47. Novartis International AG Company Details
Table 48. Novartis International AG Business Overview
Table 49. Novartis International AG Acute Myeloid Leukemia Therapeutics Product
Table 50. Novartis International AG Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Novartis International AG Recent Developments
Table 52. GlaxoSmithKline Company Details
Table 53. GlaxoSmithKline Business Overview
Table 54. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Product
Table 55. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 56. GlaxoSmithKline Recent Developments
List of Figures
Figure 1. Acute Myeloid Leukemia Therapeutics Segment by Type
Figure 2. Acute Myeloid Leukemia Therapeutics Segment by Application
Figure 3. China Acute Myeloid Leukemia Therapeutics Market Overview: 2020
Figure 4. China Acute Myeloid Leukemia Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Acute Myeloid Leukemia Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2020
Figure 7. By Type - China Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2016-2027
Figure 8. By Application - China Acute Myeloid Leukemia Therapeutics Revenue Market Share, 2016-2027
Figure 9. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Cephalon Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Novartis International AG Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs